Center for Sleep Medicine at Chestnut Hill Hospital

Philadelphia, Pennsylvania 19118

0 studies enrolling now · 2 studies all time

What they study most

Non-24-Hour Sleep-Wake Disorder

Studies at this site

• Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception — Completed
• Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder — Completed